Back to dashboard
Low impact

Tremelimumab-actl (Imjudo) (CPB 1019, reviewed 2026-04-27)

Aetna·Medical Policy
Effective date
Not stated
We identified it
Aug 18, 2026
Days to comply
—

Related policy hubs